Investor Ideas #Potcasts
548, #Cannabis News and #Stocks on the Move; (CSE: $CURA.C) (OTCQX: $CURLF),
(CSE: $HOLL.C) (OTC: $HSTRF), (CSE: $MEDI.C) and BDSA
Delta, Kelowna, BC, April 5, 2021 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/040521-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/04051CURA-HOLL-MEDI-BDSA.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Curaleaf
Holdings, Inc. (CSE:
CURA) (OTCQX:
CURLF) announced a new
Curaleaf branding for the Company's recently acquired retail locations and the
imminent opening of its 10th store in Illinois. Additionally, Curaleaf has
contributed $950,000 to impact social equity with six strategic partnerships
focused on education and job training in the greater Chicagoland community as
part of its Corporate Social Responsibility Rooted in Good initiative, and per
the Illinois Social Equity provision in adult use regulations.
Curaleaf successfully closed its
acquisition of Grassroots on July 23, 2020 and has obtained final regulatory
approval from the state of Illinois for the transfer of nine Greenhouse and
Windy City Cannabis retail licenses. In accordance with state guidelines,
Curaleaf has begun rebranding of Windy City Cannabis retail locations in Worth,
Justice, and on Weed Street in Chicago in addition to Greenhouse dispensaries
located in Deerfield, Mokena, Skokie, Northbrook, Melrose and Morris.
At the nine rebranded Illinois
retail locations, Curaleaf's signature teal logo will be prominently displayed
and as part of the new interior design, will feature hyper-local cityscape
murals that capture each store's unique location, further enhancing the
experience and connection to the community. The staff at each retail location
will remain committed to delivering unparalleled service and creating an
inclusive experience that encourages cannabis exploration and education with a
personalized approach.
Later this month, Curaleaf will be
hosting a Grand Opening for its brand new 4,700 square foot Westmont store,
located at 11 East Ogden Avenue in Westmont, Illinois, its 10th retail location
in the state and its 103rd nationwide. In addition to a ribbon cutting event to
mark the occasion, all customers will receive 15% off on purchases made on
their first visit to any of the new Curaleaf stores. All rebranded stores will
also host a "Curaleaf Day" on April 8 with special offers, giveaways
and offerings from local restaurants.
"We are pleased to bring the
Curaleaf brand to the greater Chicago area," said Joe Bayern, Curaleaf
Chief Executive Officer. "The rebranding of these locations directly
aligns with our strategy of building strong, national brands that deliver
high-quality products backed by science to meet the needs of our patients and
customers. We are also extremely proud to be active partners within these local
communities and we look forward to building collaborative relationships and
investing in long term opportunities with them."
This follows on the heels of
Curaleef’s recent
launch of
Select Squeeze, a fast-acting THC-infused beverage
enhancer featuring Nano-emulsification technology. The debut of Select Squeeze
marked a significant milestone as one of the cannabis industry's widest
national product launches. Select Squeeze was among the first cannabis products
with mass availability as it became accessible to a total addressable
population of 94 million adults age 21+.
As part of its "Rooted in
Good" Corporate Social Responsibility platform, Curaleaf has contributed a
total of $950,000 to six strategic partners in greater Chicagoland to create
opportunities and sustainable impact within the cannabis industry.
Olive-Harvey College and an
additional North Chicagoland community college have been selected to build
programs that educate, mentor and provide internships and career opportunities
within cannabis. Additionally, Curaleaf is partnering with three organizations,
Cara Chicago, Growing Home and Greater West Town Community Development Project,
which focus on job training to create economic opportunity and alleviate
relational poverty. The Company also contributed to the Illinois Cannabis
Business Development Fund, which provides technical assistance and training to
support prospective entrepreneurs in applying for cannabis business
establishment licenses.
Hollister
Biosciences Inc. (CSE:
HOLL) (OTC:
HSTRF) has
partnered with one of California's leading distributors, Nabis,
as demand for Hollister products continues to build. The new exclusive
partnership will help streamline sales, grow retail opportunities and reduce
wholesale delivery times on all orders.
Nabis supports California's cannabis
market with its wholesale distribution services. Supplying more than 99% of
California's dispensaries with a diverse selection of innovative products,
Nabis works directly with brands to ensure timely fulfillment, and provides
actionable sales data and insights to help brands scale and grow.
The partnership comes at a time when
Hollister's portfolio of products continues to gain brand awareness. HashBone,
a hash-infused pre-roll, is one of the company's signature products in
California, and Hollister recently acquired one of Arizona's leading
concentrate brands, Venom Extracts, which is coming soon to the California
market. This month, Hollister will introduce Easyriders pre-rolls in a
collectible tin as the first products from its collaboration with the iconic
motorcycle lifestyle magazine. Hollister also has product collaborations with
Tommy Chong and the veterans-aligned medicinal brand Tactical Relief.
"We are excited to be partnered
with Nabis for our last mile fulfillment. Nabis has built a best-in-class
last-mile fulfillment business that will help Hollister's brands reach more
California dispensaries with reduced lead times," says Carl Saling, the
Co-Founder, CEO and Director of Hollister Biosciences.
"While Nabis works with a wide
range of cannabis brands, we always have our eye on companies with well
established and diverse brand portfolios as potential partners," said Jun
S. Lee, President of Nabis. "Hollister Cannabis Co. joining our family of
Nabis-distributed brands is a great partnership for all parties. We look
forward to distributing Hollister's high-profile, top-quality products to dispensaries
across California."
Myconic
Capital Corp. (formerly, Auralite Investments Inc.) (CSE:
MEDI) announced that in
its pursuit to establish an investment portfolio of leading ketamine treatment
centers for depression and chronic neuropathic pain, the Company has acquired
the rights to a letter of intent providing for the acquisition of all of the
issued and outstanding shares of NY Ketamine Medical Practice PLLC, a leading
mental health and pain clinic based in New York, New York.
NY Ketamine Infusions was founded in
2012 by Dr. Glen Z. Brooks who was among the first physicians in the United
States using this innovative treatment to successfully care for patients
suffering from treatment-resistant depression, PTSD, mood disorders and chronic
neuropathic pain. Building on over 2 decades of clinical research at major
institutions like Yale University and the National Institute of Mental Health
(NIMH), Dr. Brooks was at the forefront of introducing this innovative
treatment to patients in need. Dr. Brooks is a board-certified anesthesiologist
having completed his training at Harvard’s Brigham and Women’s Hospital and has
taught at Yale University School of Medicine. As of 2021, Dr. Brooks has
treated over 4,000 patients with over 50,000 ketamine infusions in his New York
City office alone, representing the largest single office clinical experience
in the world. His internationally renowned expertise in the field of ketamine
therapy and his reputation for personal patient involvement has attracted
clients from North and South America, Europe, Asia and the Middle East.
Unlike other depression medications
that can take weeks or months to take effect, relief from ketamine infusions
can often be experienced by patients within hours, making it especially useful
for suicidal ideation. Low doses of ketamine are generally administered through
a series of six infusions over a two-week period, often followed by ongoing
maintenance sessions on an “as needed” basis. In otherwise treatment resistant
depression patients, numerous studies have shown that intravenous ketamine
therapy has an overall success rate of 70%.
Based on the success of its New York
City clinic, NY Ketamine Infusions has opened an additional clinic in Long
Island, NY (Melville). Dr. Brooks also continues to act as a consultant for
privately owned practices in Albany, NY and Madrid, Spain. He has been
interviewed and quoted in numerous publications including The New York Times
and was featured in Bloomberg Businessweek.1
Pursuant to the terms of the Letter
of Intent, Myconic would acquire NY Ketamine Infusions in exchange for
approximately USD $10,000,000, payable in cash and common shares, along with an
additional number of common shares pursuant to achieving certain milestone
events. The purchase price will be payable in three tranches collectively equal
to USD $5,000,000 in cash and USD $5,000,000 in common shares over an 18-month
period commencing upon the Company completing a financing of at least USD
$10,000,000.
The shares issued at each tranche
will be subject to an 18-month lock-up period, 25% of which will be released 4
months and 1 day from the respective share payment date; 37.5% of which will be
released 12 months from the share payment date; and 37.5% of which will be released
18 months from the share payment date.
The common shares will be issued at
a price per share equal to the volume weighted average trading price (VWAP) of
the Company’s shares on the CSE for the 30-day period preceding the issuance,
subject to the policies of the CSE and applicable securities laws. All
securities issued pursuant to the acquisition shall be subject to a four month
and one day hold period.
The completion of the acquisition is
subject to a number of conditions which include but are not limited to the
execution of the share purchase agreement and respective employment
agreement(s), applicable lease agreements, any municipal, state, or federal
licenses, copies of patents, trademarks, or intellectual property applications,
completion of satisfactory due diligence, the delivery and satisfactory review
of the financial statements of NY Ketamine Infusions, and the approval of the
transaction by the boards of directors of each of Myconic and NY Ketamine
Infusions.
BDSA, the
leader in data, market intelligence and strategic guidance to the cannabis
industry, announced
today the availability of its new Basket Analytics solution,
the most in-depth solution of its kind in the cannabis industry. BDSA Basket
Analytics is now available on BDSA’s GreenEdge™ platform.
Retailers can maximize basket sizes
and in-store experience via unique and strategic store layouts and planograms,
positioning products most likely to be purchased together on shelves to
encourage cross-sell and upsell opportunities. Further, retailers can unpack
untapped promotional programs, educate their budtenders to increase basket
size, and generate more consumer trips to the stores and higher basket sizes
when in the store.
Manufacturers and brands can build
strong retailer sales stories and relationships with quantitative proof of
their brand’s value to a store. Further, they can drive successful innovation,
better manage product portfolios, and create relevant and impactful marketing
campaigns and promotions.
BDSA can now put specifics around
how cross-brand and cross-category consumption translates to volume. Baskets
containing concentrates in Colorado, for example, are among the biggest in
dollar size. While concentrates tend to have a higher retail price, 20 percent
of the time these shoppers are also buying flower and 14 percent of the time
they are also buying edibles.
“Retailers are intently focused on
increasing basket sizes and manufacturers must create and expand penetration
within stores. Our new Basket Analytics solution with insights down to the
brand level enables all cannabis industry participants to be more successful,”
said Micah Tapman, CEO of BDSA. “More and better data enables manufacturers and
retailers to make better informed decisions that lead to increased revenue,
more effective promotions and enhanced market share. ”
BDSA solutions enable product
development and innovation, sales and marketing activities, revenue
optimization and investment decisions. Enhanced attribute coding and advanced
forecasting algorithms combine to make BDSA’s market insights invaluable tools
to review product attributes, velocity and distribution, and more.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can
trade these stocks and other ideas on our site
using our list
of top stock trading apps including Robinhood ,
Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers.
Contact management and IR of each company
directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
